|
Jul 23
|
Look Out, Eli Lilly and Novo Nordisk: Could Roche Be the Obesity Drug Stock to Really Watch?
|
|
Jun 19
|
Ascidian and Roche to develop RNA therapies for neurological diseases
|
|
Jun 18
|
Roche gains 501(k) clearance for digital pathology solution for diagnostic use
|
|
Jun 18
|
Roche partners with RNA editing biotech Ascidian
|
|
Jun 18
|
Roche receives FDA clearance on its digital pathology solution for diagnostic use
|
|
Jun 17
|
Roche (RHHBY) Reports Upbeat Data on Columvi From STARGLO Study
|
|
Jun 17
|
Roche’s Columvi offers extended survival in Phase III DLBCL trial
|
|
Jun 17
|
EHA 2024: Roche’s Columvi competes in BiTE battle with positive results in DLBCL
|
|
Jun 15
|
Roche’s Phase III STARGLO study demonstrates Columvi significantly extends survival in people with relapsed or refractory diffuse large B-cell lymphoma
|
|
Jun 15
|
Genentech’s Phase III STARGLO Study Demonstrates Columvi Significantly Extends Survival in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma
|
|
Apr 7
|
10 Best Weight Loss Drug Stocks to Buy Now
|
|
Apr 5
|
Should Weakness in Roche Holding AG's (VTX:ROG) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
|
|
Mar 29
|
15 Biggest Swiss Companies
|
|
Mar 28
|
Roche wins FDA approval for first molecular malaria blood donor screening test
|
|
Mar 27
|
Viking (VKTX) Up 17% on Encouraging Oral Obesity Drug Data
|
|
Mar 26
|
Roche receives FDA approval for the first molecular test to screen for malaria in blood donors
|
|
Feb 1
|
Health Care Roundup: Market Talk
|
|
Feb 1
|
Roche (RHHBY) 2023 Earnings Miss, COVID-19 Product Sales Down
|
|
Feb 1
|
Roche shuffles early stage pipeline as it joins obesity rush
|
|
Feb 1
|
Roche Expects Sales, Core Earnings Growth
|